23andMe's co-founder and former chief executive, Anne Wojcicki, looks set to regain control of the business after emerging ...

A nonprofit led by the co-founder and former CEO of 23andMe outbid competitors for nearly all of the company’s assets.

Then, a company named Regeneron announced they would buy the company, and would “prioritize [consumer data's] privacy, ...

In a recent investigation we took a hard look at the cybersecurity practices of major direct-to-consumer DNA testing ...

Beleaguered genetic testing company 23andMe announced Friday that it has reached an agreement to sell itself to TTAM Research ...

Anne Wojcicki's nonprofit will acquire substantially all of 23andMe's assets for $305 million, the company announced Friday.

Anne Wojcicki's nonprofit is set to purchase all significant assets of the bankrupt genetic testing company, 23andMe, for ...

A hearing this week marked a critical juncture in the national conversation about the intersection of biotechnology, privacy, ...

Nearly 2 million 23andMe users deleted their DNA data after bankruptcy. Here's why the genetic testing industry should be ...

Regeneron did not bid higher on the genetic testing company because of “its assessment of 23andMe’s remaining value,” ...

Regeneron Pharmaceuticals has declined to submit a new bid for genetic testing company 23andMe exceeding its original winning ...

House Democrats sent letters to the potential buyers of the genetic testing company, asking how they plan to protect customer ...